bpc 157 human clinical trials evidence safety fda warning KevinMD.com Regeneration or Risk? A Narrative

According to their investigative report dated Jan

And to do that all of the other delivery methods that could be used need to be thoroughly evaluated, not only as to their effectiveness in correcting the patients B12 Deficiency, but also in how the patient responds to particular delivery methods

& Plesken, H

BPC-157 lacks FDA approval for any medical condition, which means regulators have not confirmed its safety, effectiveness, dosing standards, or product quality

This novel approach was created, studied, and refined by Dr

If longer length of BE is an important predictor of progression then we should either find EAC more frequently higher up and away from the gastro-oesophageal junction (GEJ) within a LSBE or alternatively simply a long EAC involving the entire LSBE